Recruitment

Recruitment Status
Completed
Estimated Enrollment
560

Summary

Conditions
Asthma
Type
Interventional
Phase
Phase 2
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 75 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT01582503
Collaborators
Not Provided
Investigators
Study Director: Clinical Trials Genentech, Inc.